Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Unlabelled: To assess the clinical practice in the follow-up of non-muscle-invasive bladder cancer (NMIBC) among urology specialists (trainers) and residents (trainees) in Jordan.

Methods: An electronic questionnaire containing, in addition to demographic data, four questions regarding the follow-up of NMIBC was sent by e-mail to 115 urologists (53 residents and 62 specialists) selected randomly by stratified random sampling from different clinical institutions, 105 of them were returned complete.

Results: In all, 105 out of 115 (91%) questionnaires were returned complete. All of the candidates are male. For low-risk NMIBC follow-up, 46 of the specialists (79%) and 35 of the trainees (74%) decided to do a follow-up cystoscopy at 3 months after diagnosis, followed by a check cystoscopy 9 months later than yearly, while for high-risk patients, all of the specialists and 45 of the trainees (96%) decide to do a check cystoscopy every 3 months in the first 2 years after diagnosis. For upper tract follow-up in high-risk NMIBC, all of the urologists in the survey (specialists and trainees) routinely perform upper tract imaging in the form of a computed tomography scan with contrast in the first year after diagnosis. On the other hand, in the follow-up of the upper urinary tract in low-risk NMIBC, 16 of the trainees (34%) and 19 of the specialists (33%) still perform a yearly scan.

Conclusion: Because of the high recurrence rate for NMIBC, this raises the importance of adherence to guidelines in the follow-up for these patients and, at the same time to avoid overdoing unnecessary cystoscopies or upper tract scans.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129283PMC
http://dx.doi.org/10.1097/MS9.0000000000000413DOI Listing

Publication Analysis

Top Keywords

cystoscopy months
12
upper tract
12
adherence guidelines
8
follow-up
8
guidelines follow-up
8
follow-up non-muscle-invasive
8
non-muscle-invasive bladder
8
bladder cancer
8
low-risk nmibc
8
check cystoscopy
8

Similar Publications

Salvage treatment of a metastatic colorectal cancer with pMMR/MSS in a 21-year-old man: a case report.

Front Oncol

August 2025

Department of Medical Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.

In metastatic colorectal cancer (mCRC) patients with proficient mismatch repair (pMMR)/microsatellite stability (MSS), beyond third-line therapies were extremely limited. Here, we reported a case of a 21-year-old male patient with pMMR/MSS mCRC who failed to respond to both first- and second-line treatment and subsequently received non-standard third-line therapy at a local hospital. This patient was referred to our hospital, and we initiated salvage therapies.

View Article and Find Full Text PDF

Background: Junctional epidermolysis bullosa (JEB) is a rare inherited blistering disorder, and its urological spectrum remains poorly defined.

Case Presentation: A 19-month-old boy carrying compound heterozygous mutations (p.R252C, p.

View Article and Find Full Text PDF

Introduction: Acquired bladder diverticulum (BD) is typically managed using open, laparoscopic, or robotic approaches. Although transurethral techniques demonstrated favorable outcomes in the 1970s and 1980s, they have largely fallen out of favor. This study revisits transurethral endoscopic management of large, symptomatic BD, combined with Holmium laser enucleation of the prostate (HoLEP) for patients with benign prostatic obstruction (BPO) and coexisting BD.

View Article and Find Full Text PDF

Objective: This retrospective study aimed at comparing orally administered 5-aminolevulinic acid (5-ALA) to the intravesical (IV) route for the photodynamic diagnosis (PDD), follow-up, and guided transurethral resection of bladder tumors.

Materials And Methods: A comparative retrospective review was conducted on adult patients who underwent 5-ALA-assisted cystoscopy for bladder tumor detection. Participants were divided into Group A, who received oral (ALA onco) powder, while Group B received 5-ALA intravesically.

View Article and Find Full Text PDF

Objective: Idiopathic urethritis (IU) is among the causes of macroscopic hematuria in children and primarily affects males aged between 5 and 15 years. Common symptoms include dysuria and hematuria. The etiology remains incompletely understood.

View Article and Find Full Text PDF